RE: Very intresting company22 Jul 2020 10:43
Looks promising. Placing and initial payment from Eton leaves a good cash balance.
Company also received 379,474 shares in Eton which have increased in value by $700,000. Further milestones to follow with $2.5m expected in q4. Company will also receive a tiered royalty on sales ranging from low double-digits to high teens and is also due tiered sales-based milestone payments of up to $45 million in aggregate subject to annual sales thresholds.
Company will continue to seek a partner for the US development and commercialisation of Chronocort. Upfront and ongoing milestones here too?
Can any long term holders add anything further I have missed?
Good luck all.